Printer Friendly

Articles from M2 Pharma (June 19, 2018)

1-34 out of 34 article(s)
Title Author Type Words
3D imaging shown to be more effective in diagnosing arthritis. 526
AbbVie Releases Positive Outcome Data from Ongoing Upadacitinib Phase 3 Studies in Rheumatoid Arthritis. 325
Amphastar's Isoproterenol Hydrochloride Injection approved by FDA. 213
Arcuro Medical awarded US FDA regulatory clearance for SuperBall for the preservation of knee functionality. 246
Carmentix partners with UoM, CUHK and The Henan Province People's Hospital for clinical Preterm Birth study. 213
CEFALY Technology updates progress of Phase 3 Trial of Cefaly ACUTE medical device. 248
Celltrion completes CT-P6 approval re-submission to US FDA. 170
DreaMed Diabetes wins US FDA approval to market Advisor Pro in the type 1 diabetes digital market. 211
Elekta announces receipt of CE mark for Elekta Unity. 166
Eli Lilly and Company's board approves USD0.5625 per share dividend for Q3 2018. 150
Evid Science elects Marc Berger Md to SAB. 185
Evid Science names new Scientific Advisor. 276
First Generic Versions of Suboxone Sublingual Film Approved by FDA. 304
First Participant Dosed in BioMarin Phase 2 Study of Vosoritide for Treatment of Achondroplasia in Infants and Young Children. Clinical report 285
Glenmark Pharmaceuticals wins US FDA approval for first sANDA for Monroe manufacturing facility in the US. 206
GTG and Swisstec discuss plans for new joint venture. 230
Jean-Baptiste Chasseloup de Chatillon appointed as Sanofi executive VP and CFO. 191
Lustgarten-Funded Research Shows Benefit of Genetic Sequencing in Advanced Pancreatic Cancer. 311
Medicen Paris Region names StA(c)phana Roques as new chief executive officer. 105
Medivir's board to continue discussions with US FDA on proposed remetinostat phase III design. 266
Mylan NV to launch Bivalirudin for Injection in US. 177
Mylan unveils generic angiomax injection in 250 mg single-dose vial as an anticoagulant in the US. 199
NeuroVive signs exclusive licensing agreement for targeted LHON therapy with BridgeBio Pharma. 290
New Treatment for Onchocerciasis Approved by US FDA. 281
Orexo announces launch of Zubsolv in EU triggering EUR3m milestone payment. 169
Results of Phase III Study of R2 vs R-chemo in First-line Follicular Lymphoma Presented at EHA Annual Congress. 358
Sanofi completes acquisition of Ablynx. 190
Seattle Genetics Begins Phase 2 Trial of Tisotumab Vedotin in Cervical Cancer Patients. 273
Study of CLL1-CD33 Compound CAR T Cells as Treatment for Refractory Acute Myeloid Leukemia Presented at 2018EHA. 302
Study Shows Livongo for Diabetes Benefits Patients with Type 2 Diabetes. 394
Targovax ASA awarded European Patent for mutant-RAS specific neoantigen vaccine TG02. 240
UCB Study Provides Insights about Women with Chronic Rheumatic Diseases During Pregnancy. 351
X4 Pharmaceuticals' X4P-001-RD demonstrates promising activity in phase 2/3 study. 213
ZS signs digital health partnership with Rock Health. 189

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters